All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Exempt, with results | 2009-016240-40 | MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE THERAPY WITH THE COMBINATION OF BENZOYL PEROXIDE-ERYTHROMYCIN/VE... | not-yet-due | |
Exempt, with results | 2009-016241-25 | MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF THE THERAPY WITH THE COMBINATION ERYTHROMYCIN-ISOTRETINOIN/VERISF... | 2012-10-29 | not-yet-due |
Exempt, with results | 2009-017201-11 | MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (... | 2011-11-14 | not-yet-due |
Reported results Terminated | 2011-002386-38 | Μονοκεντρική, τυχαιοποιημένη, διπλή-τυφλή, συγκριτική με πρωτότυπο φάρμακο κλινική μελέτη για την αξιολόγηση της αποτελεσματικότητας και της ασφάλειας της θεραπείας με Clindamycin vaginal suppositorie... | 2015-10-19 | due-trials |
Reported results | 2012-004993-25 | A multicenter, randomized, patient-blind, investigator-blind, placebo-controlled, crossover study of Lidocaine + Prilocaine/Verisfield (2.5+2.5)% w/w cream and EMLA/AstraZeneca cream, in patients unde... | 2013-07-04 | due-trials |
Reported results | 2016-004292-41 | Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a Generic Formulation of Vaginal Ovule containi... | 2018-04-30 | due-trials |
Other | 2022-003070-23 | A multicenter, randomized, double-blind, parallel, three-arm, active- and placebo-controlled therapeutic equivalence for the comparison of clindamycin + tretinoin/Verisfield gel (1+0.025)% with Acnata... | not-yet-due |